These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25636462)

  • 21. Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic.
    Mossbrugger I; Hoelzlwimmer G; Calzada-Wack J; Quintanilla-Martinez L
    Verh Dtsch Ges Pathol; 2007; 91():98-103. PubMed ID: 18314602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
    Hruban RH; Adsay NV; Albores-Saavedra J; Anver MR; Biankin AV; Boivin GP; Furth EE; Furukawa T; Klein A; Klimstra DS; Kloppel G; Lauwers GY; Longnecker DS; Luttges J; Maitra A; Offerhaus GJ; Pérez-Gallego L; Redston M; Tuveson DA
    Cancer Res; 2006 Jan; 66(1):95-106. PubMed ID: 16397221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinogenesis studies in mice with genetically engineered alterations in polyamine metabolism.
    Feith DJ
    Methods Mol Biol; 2011; 720():129-41. PubMed ID: 21318870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical use of advanced mouse models for lung cancer.
    Safari R; Meuwissen R
    Methods Mol Biol; 2015; 1267():93-124. PubMed ID: 25636466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response.
    DuPage M; Jacks T
    Curr Opin Immunol; 2013 Apr; 25(2):192-9. PubMed ID: 23465466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of mouse models for the analysis of human disease.
    Semsarian C
    Curr Protoc Hum Genet; 2002 May; Chapter 15():Unit 15.2. PubMed ID: 18428327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human tumor xenografts and mouse models of human tumors: re-discovering the models.
    Teicher BA
    Expert Opin Drug Discov; 2009 Dec; 4(12):1295-305. PubMed ID: 23480467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetically engineered mice and its application to bioindustry].
    Koda T; Togashi Y; Nishimura T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):151-6. PubMed ID: 11968850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression.
    Pylayeva Y; Guo W; Giancotti FG
    Methods Enzymol; 2007; 426():439-61. PubMed ID: 17697895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically engineered animal models for in vivo target identification and validation in oncology.
    Texidó G
    Methods Mol Biol; 2013; 986():281-305. PubMed ID: 23436419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of inter-simple sequence repeat PCR to mouse models: assessment of genetic alterations in carcinogenesis.
    Benavides F; Zamisch M; Flores M; Campbell MR; Andrew SE; Angel JM; Licchesi J; Sternik G; Richie ER; Conti CJ
    Genes Chromosomes Cancer; 2002 Dec; 35(4):299-310. PubMed ID: 12378524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Mouse Tumor Biology Database: integrated access to mouse cancer biology data.
    Krupke D; Näf D; Vincent M; Allio T; Mikaelian I; Sundberg J; Bult C; Eppig J
    Exp Lung Res; 2005 Mar; 31(2):259-70. PubMed ID: 15824024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-engineered models for genetic manipulation and functional analysis of the cardiovascular system in mice.
    Chu PH; Lu JT; Chen J
    Chang Gung Med J; 2003 Dec; 26(12):868-78. PubMed ID: 15008321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetically engineered knock-in and conditional knock-in mouse models of cancer.
    Rappaport A; Johnson L
    Cold Spring Harb Protoc; 2014 Sep; 2014(9):897-911. PubMed ID: 25183823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse models of human breast cancer.
    Cardiff RD
    Comp Med; 2003 Jun; 53(3):250-3. PubMed ID: 12868567
    [No Abstract]   [Full Text] [Related]  

  • 38. Chromosomal translocation engineering to recapitulate primary events of human cancer.
    Forster A; Pannell R; Drynan L; Cano F; Chan N; Codrington R; Daser A; Lobato N; Metzler M; Nam CH; Rodriguez S; Tanaka T; Rabbitts T
    Cold Spring Harb Symp Quant Biol; 2005; 70():275-82. PubMed ID: 16869763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.
    Namba R; Maglione JE; Young LJ; Borowsky AD; Cardiff RD; MacLeod CL; Gregg JP
    Mol Cancer Res; 2004 Aug; 2(8):453-63. PubMed ID: 15328372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically engineered murine models of prostate cancer: insights into mechanisms of tumorigenesis and potential utility.
    Abdulkadir SA; Kim J
    Future Oncol; 2005 Jun; 1(3):351-60. PubMed ID: 16556009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.